[ ALIGNING SCIENCE ACROSS PARKINSON’S - ASAP Collaborative Research Network | Research Funding ]
Event details
| Date | 08.01.2020 |
| Category | Call for proposal |
Aim: The ASAP initiative will accept applications to support multidisciplinary research teams to form the ASAP Collaborative Research Network. ASAP seeks to fund research projects to address key knowledge gaps in the basic mechanisms that contribute to Parkinson’s development and progression.
Applications must focus on one of the following scientific themes:.
This RFA is aimed at investigations focused solely on underlying disease biology, including research aimed at understanding the structure and function of the nervous system and related physiological systems. Can involve studies performed in vitro, in animals, or in humans.
Funding: max. $3’000’000 / year
Duration: max. 3 years
Eligibility: The request for applications is open to international organizations including public and private non-profit groups, agencies of the U.S. federal government, and for-profit entities. Applications must be submitted by multidisciplinary, multi-institutional research teams:
How to Apply: There is a three-step proposal process: A preproposal is submitted first; it should be composed using the template provided to create an executive summary of the experimental plan, research impact, and team makeup. Upload a PDF copy with your online submission. Selected applicants will be invited to submit a full proposal in the second step. Finally, finalists will be chosen and interviewed (virtually) by ASAP leadership in a third step. ASAP is leveraging The Michael J. Fox Foundation’s (MJFF) grants infrastructure for this initiative. All pre-proposals must be submitted through the MJFF Grant Portal.
Deadline (Pre-proposal): 08 January 2020 (6:00 pm EST)
Deadline (Full Application, by invitation): 15 April 2020 (6:00 pm EST)
Further information
Applications must focus on one of the following scientific themes:.
- Biology of PD-associated Genetics
- Neuro-Immune Interactions
This RFA is aimed at investigations focused solely on underlying disease biology, including research aimed at understanding the structure and function of the nervous system and related physiological systems. Can involve studies performed in vitro, in animals, or in humans.
Funding: max. $3’000’000 / year
Duration: max. 3 years
Eligibility: The request for applications is open to international organizations including public and private non-profit groups, agencies of the U.S. federal government, and for-profit entities. Applications must be submitted by multidisciplinary, multi-institutional research teams:
- Three to five investigators including a Coordinating Principal Investigator (PI) and up to four additional Co-Investigators (Co-Is)
- A minimum of two participating institutions (but no more than five)
- At least one early career investigator, within one (1) to seven (7) years of their first independent appointment, in the position of Co-I
- At least two different disciplines represented on each team
- All Key Personnel must hold a doctorate, such as a PhD, MD, or equivalent degree, and be in an independent faculty position or equivalent.
How to Apply: There is a three-step proposal process: A preproposal is submitted first; it should be composed using the template provided to create an executive summary of the experimental plan, research impact, and team makeup. Upload a PDF copy with your online submission. Selected applicants will be invited to submit a full proposal in the second step. Finally, finalists will be chosen and interviewed (virtually) by ASAP leadership in a third step. ASAP is leveraging The Michael J. Fox Foundation’s (MJFF) grants infrastructure for this initiative. All pre-proposals must be submitted through the MJFF Grant Portal.
Deadline (Pre-proposal): 08 January 2020 (6:00 pm EST)
Deadline (Full Application, by invitation): 15 April 2020 (6:00 pm EST)
Further information
- See the official webpage for more details, or download the RFA
- Find the application portal here
- Participate in the informational webinar on 14 November to learn more
Practical information
- General public
- Free